Microsatellite instability in endometrioid endometrial carcinoma: Correlation with clinically relevant pathologic variables

International Journal of Gynecological Cancer

Volumn 16, Issue 3, 2006, Pages 1386-1392

  Honore, L H ^a   Hanson, J ^a   Andrew, S E ^b  

^a CROSS CANCER INSTITUTE   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

BAT26; Clinicopathologic variables; Endometrioid endometrial carcinoma; Microsatellite instability; Statistical analysis

Indexed keywords

ADENOMYOSIS; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER LOCALIZATION; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOMETRIOID CARCINOMA; ENDOMETRIUM ATROPHY; ENDOMETRIUM CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; METASTASIS; MICROSATELLITE INSTABILITY; MOLECULAR GENETICS; PRIORITY JOURNAL; SQUAMOUS CELL METAPLASIA; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, ENDOMETRIOID; CHROMOSOMAL INSTABILITY; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MICROSATELLITE REPEATS; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; NEOPLASM INVASIVENESS; PROGNOSIS;

EID: 33745077931     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2006.00535.x     Document Type: Article

References (66)

1. Lengauer C Kinzler KW Vogelstein B. Genetic instability in colorectal cancers. Nature 1997 386: 623 7.
2. Tibiletti MG Furlan D Taborelli M et al. Microsatellite instability in endometrial cancer: relation to histological subtypes. Gynecol Oncol 1999 73: 247 52.
3. Faquin WC Fitzgerald JT Lin M-C Boynton KA Muto MG Mutter GL. Sporadic microsatellite instability is specific to neoplastic and preneoplastic endometrial tissues. Am J Clin Pathol 2000 113: 576 82.
4. Ellenson LH. hMLH1 promoter hypermethylation in microsatellite instability-positive endometrial carcinoma. Cause or consequence? Am J Pathol 1999 155: 1399 402.
5. Esteller M Catasus L Matias-Guiu X et al. hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis. Am J Pathol 1999 155: 1767 72.
6. Gurin CC Federici MG Kang L Boyd J. Causes and consequences of microsatellite instability in endometrial carcinoma. Cancer Res 1999 59: 462 8.
7. Stefansson I Akslen LA MacDonald N et al. Loss of hMSH2 and hMSH6 expression is frequent in sporadic endometrial carcinomas with microsatellite instability: a population-based study. Clin Cancer Res 2002 8: 138 43.
8. Duval A Hamelin R. Alterations at coding repeat sequences in mismatch repair-deficient human cancers: toward a new concept of target genes for instability. Cancer Res 2002 62: 2447 54.
9. Woerner SM Benner A Sutter C et al. Pathogenesis of DNA repair-deficient cancers: a statistical meta-analysis of putative common target genes. Oncogene 2003 22: 2226 35.
10. Perucho M. Tumors with microsatellite instability: many mutations, targets and paradoxes. Oncogene 2003 22: 2223 5.
11. Maxwell GL Risinger JI Alvarez AA Barrett JC Berchuk A. Favorable survival associated with microsatellite instability in endometrioid endometrial cancers. Obstet Gynecol 2001 97: 417 22.
12. Caduff RF Johnston CM Svoboda-Newman SM Poy EL Merajver SD Frank TS. Clinical and pathological significance of microsatellite instability in sporadic endometrial carcinoma. Am J Pathol 1996 148: 1671 8.
13. Catasus L Machin P Matias-Guiu X Prat J. Microsatellite instability in endometrial carcinomas: clinicopathologic correlations in a series of 42 cases. Hum Pathol 1998 29: 1160 4.
14. Palmieri G Manca A Cossu A et al. Microsatellite analysis at 10 q25-q26 in Sardinian patients with sporadic endometrial carcinoma. Cancer 2000 89: 1773 82.
15. Muresu R Sini MC Cossu A et al. Chromosomal abnormalities and microsatellite instability in sporadic endometrial cancer. Eur J Cancer 2002 38: 1802 9.
16. Berends MJW Wu Y Sijmons RH et al. Toward new strategies to select young endometrial cancer patients for mismatch repair gene mutation analysis. J Clin Oncol 2003 21: 4364 70.
17. Hirasawa A Aoki D Inoue J et al. Unfavorable prognostic factors associated with high frequency of microsatellite instability and comparative genomic hybridization analysis in endometrial cancer. Clin Cancer Res 2003 9: 5675 82.
18. Zaino RJ Kurman RJ Diana KL Morrow CP. Pathologic models to predict outcome for women with endometrial carcinoma. Cancer 1996 77: 1115 21.
19. Sidawy MK Silverberg SG. Endometrial carcinoma. Pathologic factors of therapeutic and prognostic significance. Pathol Annu 1992 27: 153 85.
20. Hoang JM Cottu PH Thuille B et al. An indicator of the replication error phenotype in colorectal cancers and cell lines. Cancer Res 1997 57: 300 3.
21. Zhou XP Hoang JM Li YJ et al. Determination of the replication error phenotype in human tumors without the requirement for matching normal DNA by analysis of mononucleotide repeat microsatellites. Genes Chromosomes Cancer 1998 21: 101 7.
22. Pyatt R Chadwick RB Johnson CK et al. Polymorphic variation at the BAT-25 and BAT-26 loci in individuals of African origin. Implications for microsatellite instability testing. Am J Pathol 1999 155: 349 53.
23. Samowitz WS Slattery ML Potter JD et al. BAT-26 and BAT-40 instability in colorectal adenomas and carcinomas and germline polymorphisms. Am J Pathol 1999 154: 1637 41.
24. Mukherjee M Minal V Mittal RD et al. Allelic variation of BAT-26 and BAT-40 poly-adenine repeat loci in North Indians. Int J Mol Med 2002 9: 91 4.
25. Chapusot C Martin L Laurent Puig P et al. What is the best way to assess microsatellite instability status in colorectal cancer. Am J Surg Pathol 2004 28: 1553 9.
26. Pijnenborg JMA Dam-De Veen GC de Haan J van Engeland M Groothuis PG. Defective mismatch repair and development of recurrent endometrial carcinoma. Gynecol Oncol 2004 94: 550 9.
27. Schlosshauer PW Pirog EC Levine RL Ellenson LH. Mutational analysis of the CTNNB1 and APC genes in uterine endometrioid carcinoma. Mod Pathol 2000 13: 1066 72.
28. Matias-Guiu X Catasus L Bussaglia E et al. Molecular pathology of endometrial hyperplasia and carcinoma. Hum Pathol 2001 32: 569 77.
29. Hermeking H Rago C Schuhmacher M et al. Identification of CDK4 as a target for C-Myc. Proc Natl Acad Sci U S A 2000 97: 2229 34.
30. Mitchell KA El-Deiry WS. Overexpression of C-Myc inhibits p21 WAF1/CIP1 expression and induces S-phase entry in 12-0-tetradecanoyl phorbol-13-acetate (TPA)-sensitive human cancer cells. Cell Growth Differ 1999 10: 223 30.
31. Spencer CA Groudine M. Control of C-Myc regulation in normal and neoplastic cells. Adv Cancer Res 1991 56: 1 48.
32. Saegusa M Hamano M Kuwata T et al. Up-regulation and nuclear localization of beta-catenin in endometrial carcinoma in response to progesterone therapy. Cancer Sci 2003 94: 103 11.
33. Guo QM Malek RL Kim S et al. Identification of C-Myc responsive genes using rat cDNA microarray. Cancer Res 2000 60: 5922 8.
34. Mariani A Webb MJ Keeney GL Lesnick TG Podratz KC. Surgical stage I endometrial cancer: predictors of distal failure and death. Gynecol Oncol 2002 87: 274 80.
35. Plentl AA Friedman EA. Lymphatics of the corpus uteri. In: Lymphatic system of the female genitalia, Vol. 2 in the series Major Problems in Obstetrics and Gynecology Consulting. Friedman EA. Philadelphia, London, Toronto: WB Saunders Company, 1971: 117.
36. Bussaglia E del Rio E Matias-Guiu X Prat J. PTEN mutations in endometrial carcinomas: a molecular and clinicopathologic analysis of 38 cases. Hum Pathol 2000 31: 312 7.
37. Salvesen HB MacDonald N Ryan A et al. PTEN methylation is associated with advanced stage and microsatellite instability in endometrial carcinoma. Int J Cancer 2001 91: 22 6.
38. Jones RJ Brunton VG Frame MC. Adhesion-linked kinases in cancer: emphasis on SRC, focal adhesion kinase and PI3-kinase. Eur J Cancer 2000 36: 1595 606.
39. Tamura M Gu J Tran H Yamada KM. PTEN gene and integrin signaling in cancer. J Natl Cancer Inst 1999 91: 1820 8.
40. Thompson JE Thompson CB. Putting the rap on AKT. J Clin Oncol 2004 22: 4217 26.
41. Bilton RL Booker GW. The subtle side to hypoxia inducible factor (HIFα) regulation. Eur J Biochem 2003 270: 791 8.
42. Arsham AM Plas DR Thompson CB Simon MC. Akt and hypoxia-inducible factor-1 independently enhance tumor growth and angiogenesis. Cancer Res 2004 64: 3500 7.
43. Salvesen HB Stefansson I Kalvenes MB Das S Akslen LA. Loss of PTEN expression is associated with metastatic disease in patients with endometrial carcinoma. Cancer 2002 94: 2185 91.
44. Tobioka H Isomura H Kokai Y Tokunaga Y Yamaguchi J Sawada N. Occludin expression decreases with the progression of human endometrial carcinoma. Hum Pathol 2004 35: 159 64.
45. Dai D Wolf DM Litman ES White MJ Leslie KK. Progesterone inhibits human endometrial cancer cell growth and invasiveness: down-regulation of cellular adhesion molecules through progesterone B receptors. Cancer Res 2002 62: 881 6.
46. Clarke CL Sutherland RL. Progestin regulation of cellular proliferation. Endocr Rev 1990 11: 266 301.
47. Liu FS Dong J-T Chen J-T et al. KAI1 metastasis suppressor protein is down-regulated during the progression of human endometrial cancer. Clin Cancer Res 2003 9: 1393 8.
48. Aglund K Rauvala M Puistola U et al. Gelatinases A and B (MMP-2 and MMP-9) in endometrial cancer - MM-9 correlates to the grade and the stage. Gynecol Oncol 2004 94: 699 704.
49. Giri D Ittmann M. Inactivation of the PTEN tumor suppressor gene is associated with increased angiogenesis in clinically localized prostate carcinoma. Hum Pathol 1999 30: 419 24.
50. Lu Y Lin Y-Z LaPushin R et al. The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cells. Oncogene 1999 18: 7034 45.
51. Sivridis E Giatromanolaki A. Proliferative activity in postmenopausal endometrium: the lurking potential for giving rise to an endometrial adenocarcinoma. J Clin Pathol 2004 57: 840 9.
52. Kaku T Tsukamoto N Hachisuga T et al. Endometrial carcinoma associated with hyperplasia. Gynecol Oncol 1996 60: 22 5.
53. Yager JD. Endogenous estrogens as carcinogens through metabolic activation. J Natl Cancer Inst Monogr 2000 27: 67 73.
54. Nakagawa H Nuovo GJ Zervos EE et al. Age-related hypermethylation of the 5/region of MLH1 in normal colonic mucosa is associated with microsatellite-unstable colorectal cancer development. Cancer Res 2001 61: 6991 5.
55. Schink JC Lurain JR Wallemark CB Chmiel JS. Tumor size in endometrial cancer: a prognostic factor for lymph node metastasis. Obstet Gynecol 1987 70: 216 9.
56. Mariani A Webb MJ Keeney GL Aletti G Podratz KC. Predictors of lymphatic failure in endometrial cancer. Gynecol Oncol 2002 84: 437 42.
57. Touboul E Belkacemi Y Buffat L et al. Adenocarcinoma of the endometrium treated with combined irradiation and surgery: study of 437 patients. Int J Radiat Oncol Biol Phys 2001 50: 81 97.
58. Lee KR Vacek PM Belinson JL. Traditional and non-traditional histopathologic predictors of recurrence in uterine endometrial adenocarcinoma. Gynecol Oncol 1994 54: 10 8.
59. Ambros RA Kurman RJ. Combined assessment of vascular and myometrial invasion as a model to predict prognosis in stage I endometrioid adenocarcinoma of the uterine corpus. Cancer 1992 69: 1424 31.
60. Yamazawa K Seki K Matsui H Sekiya S. Significance of perivascular lymphocytic infiltrates in endometrial carcinoma. Cancer 2001 91: 1777 84.
61. Kihana T Fujioka T Hamada K et al. Association of replication error positive phenotype with lymphocytic infiltration in endometrial cancers. Jpn J Cancer Res 1998 89: 895 902.
62. Zaino RJ Kurman RJ Herbold D et al. The significance of squamous differentiation in endometrial carcinoma. Cancer 1991 68: 2293 302.
63. Abeler VM Kjorstad KE. Endometrial adenocarcinoma with squamous differentiation. Cancer 1992 69: 488 95.
64. Prat J. Prognostic parameters of endometrial carcinoma. Hum Pathol 2004 35: 649 62.
65. Peiro G Diebold J Lohse P et al. Microsatellite instability, loss of heterozygosity and loss of hMLH1 and hMSH2 protein expression in endometrial carcinoma. Hum Pathol 2002 33: 347 354.
66. Boland CR Thibodeau SN Hamilton SR et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 1998 58 ( 2): 5248 57.